Nautilus Biotechnology, Inc. NAUT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.19% | 3.75% | 11.53% | 21.67% | 17.46% |
| Total Depreciation and Amortization | -19.46% | -21.37% | -9.17% | -2.99% | 0.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.25% | -7.87% | -20.47% | -58.94% | -51.65% |
| Change in Net Operating Assets | 2.97% | -40.25% | -103.65% | 5.53% | 63.65% |
| Cash from Operations | -20.36% | -2.82% | 6.01% | 13.52% | 15.85% |
| Capital Expenditure | -245.69% | -14.65% | -132.88% | 75.94% | 41.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,265.86% | -16.10% | -25.28% | -97.30% | 112.81% |
| Cash from Investing | 2,209.29% | -16.94% | -27.05% | -97.88% | 106.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 156.84% | 6,038.89% | -77.05% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 156.84% | 6,038.89% | -77.05% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 73.38% | -219.77% | -59.98% | -149.43% | 48.32% |